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To determine the regulatory mechanism for human tyrosine hydroxylase, we examined modulations ofthe activity of 
the enzyme from human pheochromocytoma by cyclic AMP-dependent protein kinase, calmodulin-dependent protein 
kinase II and polyanion. The most remarkable activation was observed when the enzyme was assayed at physiological 
pH (pH 7) after being subjected tophosphorylation by cyclic AMP-dependent protein kinase. Calmodulin-dependent 
protein kinase II and polyanion also modulated the enzyme activity. The results uggest that tyrosine hydroxylase may 
be regulated similarly in both human and rat. 
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1. INTRODUCTION 
Tyrosine hydroxylase (L-tyrosine, tetrahydro- 
pteridine: oxygen oxidoreductase (3-hydroxy- 
lating), EC 1.14.16.2) catalyzes the conversion of 
L-tyrosine to L-dopa, which is the initial and rate- 
limiting step in the biosynthesis of catecholamines 
in the nervous system [1,2] and, therefore, the 
regulation of its activity is particularly important. 
The regulatory mechanism for the rat or bovine en- 
zyme has so far been extensively studied and a 
variety of mechanisms, including end-product 
feedback inhibition [1,3], inactivation by end- 
products [4], modulation by polyanions [5] or an 
anionic detergent such as SDS [6], and activation 
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by protein kinases such as cAMP-dependent pro- 
tein kinase [7-10] and calmodulin-dependent pro- 
tein kinase II [11,12] have been demonstrated to
modulate the enzyme activity reversibly. 
In contrast to the rat or bovine enzyme, the 
human enzyme has recently been reported to be 
not significantly activated by cAMP-dependent 
protein kinase and calmodulin-dependent protein 
kinase II [13]. Thus, the question has been raised 
whether a regulatory mechanism similar to that for 
rat or bovine tyrosine hydroxylase can exert its ef- 
fect on the activity of human tyrosine hydroxylase. 
In the present study, effects of cAMP-dependent 
protein kinase, calmodulin-dependent protein 
kinase II and polyanion on the activity of tyrosine 
hydroxylase from human pheochromocytoma 
have been examined and compared with those on 
the activity of the enzyme from rat 
pheochromocytoma cell, PC12. The results 
demonstrate for the first time that human tyrosine 
hydroxylase may be regulated by a mechanism 
similar to that of the rat enzyme. 
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2. MATERIALS  AND METHODS 
L-[l-~4C]Tyrosine (52mCi/mmol) was purchased from 
Amersham. Catalase from bovine liver, phosphoenolpyruvate 
and pyruvate kinase from rabbit muscle were from Boehringer. 
Dithiothreitol, p-chloromercuribenzenesulfonic acid, dex- 
amethasone acetate, EGTA, Mes, Hepes and ATP were from 
Sigma. 6R-L-erythro-5,6,7,8-Tetrahydrobiopterin, a roduct of 
Suntory Biomedical Institute, Osaka, was a generous gift of Dr 
Osamu Hayalshi, Osaka Bioscience Institute, Osaka. Dextran 
sulfate was from Pharmacia. The clonal PC12 rat 
pheochromocytoma cell line [14] was kindly donated by Dr 
Takehiko Amano, Mitsubishi-Kasei Institute of Life Sciences, 
Tokyo. RPMI 1640 medium was from Nissui, Japan. Fetal calf 
serum and horse serum were from Gibco. Bio-Gel P-10 was 
from BioRad. Leupeptln, chymostatin a d pepstatin were from 
Peptide Institute, Osaka. 
The catalytic subunit of cAMP-dependent protein kinase was 
purified from bovine heart essentially according to the method 
of Sugden et al. [15] up to the second hydroxyapatite step. 
Calmodulin-dependent protein kinase II [16] and activator 
protein [17] were purified from rat cerebral cortex as described 
previously. 
Calmodulin was purified from rat testis by the method of 
Dedman et al. [18]. 
PCI2 cells were cultured in RPMI medium supplemented 
with 5°7o fetal calf serum and 1007o horse serum at 37°C. Dex- 
amethasone (1/zM) was added to the medium 2 days before 
harvest to enhance the yield of tyrosine hydroxylase [19]. The 
harvested cells were stored at -80°C until use. 
Frozen human pheochromocytoma (about 30 mg) and frozen 
PCI2 cells (1.3 g) were homogenized in 0.3 ml and 4.4 ml, 
respectively, of 5 mM sodium phosphate buffer (pH 7.5) con- 
taining 20/~g/ml each of leupeptin, chymostatin and pepstatin 
in a Potter-Elvehjem homogenizer and each supernatant, ob- 
tained by centrifugation for 60 min at 100000 x g, was passed 
through a Bio-Gel P-10 column in 5 mM sodium phosphate 
buffer (pH 7.5) to remove low molecular mass ubstances. The 
resulting crude extracts were stored in aliquots at -80°C until 
use. 
Tyrosine hydroxylase was assayed radiometrically based on 
~4CO2 evolution through coupled non-enzymatic decarboxyla- 
tion of L-[1-14Cldopa formed from L-[l-14C]tyrosine according 
to the method escribed previously [4,20], except that Mes (pH 
5.0-7.0) and Hepes (pH 7.0-7.5) in place of Hepes (pH 7.0), 
1 mM 6R-L-erythro-5,6,7,8-tetrahydrobiopterin in place of 
1 mM 
2-amino-4-hydroxy-6-methyl-5,6,7,8-tetrahydropteridine, and 
10/~M tyrosine in the place of 200/~M tyrosine were used. 
When the enzyme activity was measured after exposure to en- 
zymatic phosphorylating conditions, the incubation mixture for 
the phosphorylation by cAMP-dependent protein kinase con- 
tained 5 mM sodium phosphate buffer (pH 7.5), 0.1 mM 
EGTA, 3 mM phosphoenolpyruvate (pH 7), 10/~g of pyruvate 
kinase, 0.1 mM ATP, 5 mM magnesium acetate, 4.3/zg of the 
catalytic subunit of cAMP-dependent protein kinase and 
suitable amounts of the crude extract from the human 
pheochromocytoma or the crude extract from the PCI2 ceils, in 
a final volume of 100/zl. For the incubation mixture for the 
reaction of calmodulin-dependent protein kinase II, the 
catalytic subunit was replaced by 1.05/~g of calmodulin- 
dependent protein kinase II, 3.5 ,ug of calmodulin, 4.5/~g of ac- 
tivator protein and 0.12 mM CaC12. After incubation for 3 min 
at 30°C, tyrosine hydroxylase activity was measured as describ- 
ed above. One unit of the activity of tyrosine hydroxylase was 
defined as the amount of enzyme that catalyzed the formation 
of 1 nmol of dopa/min at 30°C. 
3. RESULTS AND DISCUSSION 
Effects of cAMP-dependent  protein kinase, 
calmodul in-dependent protein kinase II, or poly- 
an ion on the activity of human tyrosine hydroxyl- 
ase were examined and compared with those on the 
activity of the rat enzyme as shown in fig. 1. Since 
only about 30 mg of human pheochromocytoma 
was available for the experiment, he assay condi- 
t ions were chosen so that the sensitivity of the 
assay was as high as possible, cAMP-dependent  
protein kinase markedly activated the human en- 
zyme as well as the rat enzyme, and the activated 
enzymes both exhibit pH optima at the physiologi- 
cal pH (pH 7). Calmodul in-dependent protein 
kinase II did not cause an appreciable increase in 
the activity measured at a neutral pH but it caused 
an increase in the activity measured at an acidic pH 
of both the human and rat enzymes. A polyanion 
such as dextran sulfate caused an increase in the 
activity measured over the pH range 6 -7  and a 
decrease in the activity measured at an acidic pH of 
both the enzymes. Thus, the modes of the modula-  
tions of the human and rat enzymes by cAMP-  
dependent protein kinase, calmodul in-dependent 
protein kinase II and polyanion appeared to be 
essentially identical. The pH profile of the enzyme 
activity of the crude extract from human 
pheochromocytoma w s apparently distinct from 
that of the crude extract from PC12 cells. Since 
treatment of the enzyme with trypsin [21,22] or 
Ca2÷-dependent neutral protease, calpain [23], was 
reported to result in an increase in the activity 
measured at a neutral pH, the apparent difference 
may be due to partial proteolysis in the human 
sample. 
From the results obtained from the in vitro 
studies with rat tyrosine hydroxylase, we have pro- 
posed a molecular mechanism for the regulation of 
tyrosine hydroxylase that calmodul in-dependent 
protein kinase II is involved in the depolarization- 
induced activation and cAMP-dependent protein 
kinase is involved in the autoreceptor-mediated ac- 
t ivation of tyrosine hydroxylase in the nerve ter- 
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Fig. 1. Effects of cAMP-dependent protein kinase, calmodulin- 
dependent protein kinase II and polyanion on pH profile of the 
activity of human and rat tyrosine hydroxylase. Tyrosine 
hydroxylase activity of the crude extract from human 
pheochromocytoma (A) and rat PC12 cells (B) was measured as 
described in section 2 in the absence (e) or presence (o) of 
100 #g/ml dextran sulfate, after activation by cAMP-dependent 
protein kinase (A), and after activation by calmodulin- 
dependent protein kinase II (A). 
minal  [24,25]. Recent studies conducted in rat 
striatal slices suggest he possible involvement of 
calmodul in-dependent protein kinase II in the 
depolarization-induced activation of tyrosine 
hydroxylase [26-28], providing strong support for 
our proposed mechanism. Richtand et al. [29] have 
reported that heparin is effective in stabilizing 
tyrosine hydroxylase and accelerates the 
phosphorylat ion of the enzyme by cAMP- 
dependent protein kinase and further suggested 
that polyanions may act as a physiological effector 
of tyrosine hydroxylase in concert with cAMP-  
dependent protein kinase. The present study sug- 
gests that human tyrosine hydroxylase also may be 
regulated by the regulatory mechanism similar to 
that for rat tyrosine hydroxylase. 
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